+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coronary Interventional Devices Market - Global Forecast to 2030- Product Image
Coronary Interventional Devices Market - Global Forecast to 2030- Product Image
New

Coronary Interventional Devices Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6084714
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The burden of coronary artery disease continues to drive demand for advanced interventional solutions, compelling clinicians and manufacturers to innovate at an unprecedented pace. As the prevalence of atherosclerosis and acute coronary syndromes rises, interventional cardiology has shifted from crude balloon angioplasty to a sophisticated array of devices designed to restore vessel patency, minimize restenosis and improve patient outcomes. Recent developments in bioabsorbable scaffolds, cutting‐edge guidewire coatings and nanotechnology‐enabled imaging have redefined procedural precision.

The convergence of material science, device engineering and digital health platforms is transforming how interventions are planned and executed. Integration of intravascular imaging, physiologic assessment tools and robot‐assisted navigation reduces procedural times and enhances lesion targeting. Meanwhile, evolving clinical guidelines and growing emphasis on value‐based care underscore the need for devices that deliver efficacy while controlling costs.

This executive summary provides an authoritative overview of the transformative forces reshaping the coronary interventional devices market, from regulatory shifts and tariff impacts to nuanced segmentation and regional dynamics. Through in‐depth insights, the report equips decision‐makers with the clarity needed to navigate this complex, high‐stakes environment.

Transformative Shifts Redefining Device Innovation and Adoption

Interventional cardiology is undergoing a paradigm shift driven by innovations that extend beyond incremental improvements. Minimally invasive techniques now account for the majority of coronary procedures, powered by orbital, laser and rotational atherectomy systems that precisely debulk calcified lesions. Concurrently, the emergence of nanoengineered coatings and drug‐eluting platforms augments healing and reduces the risk of late thrombosis.

Artificial intelligence and machine learning are being integrated into imaging modalities and decision‐support software, enabling real‐time lesion assessment and personalized therapy planning. Cloud‐connected cath labs are optimizing workflow, while tele‐mentoring platforms bridge expertise gaps across geographies. Furthermore, regulatory bodies in key markets are streamlining pathways for breakthrough devices and harmonizing approval processes, accelerating time to market without compromising safety.

These transformative shifts demand agility from stakeholders across the value chain. Manufacturers must anticipate evolving clinical needs and regulatory requirements, whereas healthcare providers must invest in training and infrastructure to harness new capabilities. The result is a more dynamic market landscape where collaboration and adaptability are paramount.

Assessing the 2025 US Tariff Impacts on Device Supply Chains and Costs

The introduction of United States tariffs on select medical device imports in 2025 has generated both operational challenges and strategic opportunities. Increased duties on raw materials and finished devices have put upward pressure on pricing, compelling manufacturers to reassess supply chain footprints and negotiate new sourcing agreements. Device makers with vertically integrated operations or domestic manufacturing capabilities have experienced relative insulation from cost inflation, while those reliant on low‐cost overseas suppliers face margin compression.

In response, many global companies are accelerating onshore production, forging joint ventures with domestic partners or establishing toll manufacturing facilities to mitigate tariff exposure. Advanced component localization and the adoption of nearshoring strategies are becoming standard practices. Meanwhile, contract research organizations and logistics providers are adapting their offerings to support agile inventory management, ensuring continuity of supply in the face of evolving trade policies.

Clinicians are sensitive to cost trends, and hospitals are negotiating bundled pricing agreements to offset tariff‐driven increases. As purchasers demand greater transparency and value, device developers are incorporating total cost of ownership analyses into their value propositions, demonstrating long‐term savings through reduced complication rates and shorter hospital stays.

Key Insights from Multi‐Dimensional Market Segmentation

A granular segmentation analysis reveals critical opportunities and risk factors across multiple dimensions of the coronary interventional devices market. When segmenting by device type, atherectomy systems-spanning laser, orbital and rotational modalities-are particularly vital for managing calcified lesions, while catheter technologies such as balloon, diagnostic and guiding catheters remain the workhorses of routine interventions. Embolic protection solutions, including distal occlusion, filter and proximal occlusion devices, are gaining traction in complex plaque scenarios. Guidewires with hydrophilic versus non‐hydrophilic coatings determine trackability, and stent platforms ranging from bare metal and stainless steel to bioresorbable vascular scaffolds and dual therapy stents drive differentiation.

End users present diverse demand profiles: university hospitals and research labs in academic and research institutes pioneer first‐in‐human trials, multispecialty and single specialty ambulatory surgical centers optimize cost‐effective elective procedures, and private versus public hospitals balance commercial imperatives with access mandates. Material type segmentation underscores the shift toward nickel‐titanium and cobalt‐chromium alloys in metallic stents, while biodegradable polymers in fully and partially degradable scaffolds are challenging legacy stainless steel implants.

Procedure type distinctions between atherectomy, balloon and laser angioplasty versus transcatheter valve replacement and repair delineate investment priorities in interventional suites. Patient demographics, including adult, geriatric and pediatric age brackets as well as gender differences, inform device sizing and therapeutic risk‐benefit assessments. Application types in coronary artery disease, peripheral artery disease or structural heart disease each carry unique regulatory and reimbursement pathways, while bioabsorbable technology platforms, novel scaffolding techniques and nanotechnology use cases represent the frontier of device advancement.

Regional Dynamics Driving Device Adoption and Access

Regional dynamics are shaping competitive positioning and adoption curves in distinct ways. In the Americas, particularly the United States, high procedural volumes, reimbursement incentives for complex interventions and a robust clinical trial ecosystem drive rapid uptake of next‐generation devices. Latin America’s growth is supported by expanding private healthcare networks, though cost sensitivity remains a barrier.

In Europe, Middle East & Africa, Europe’s unified regulatory framework fosters cross‐border device approvals and pan‐European registries that accelerate real‐world evidence generation. Gulf Cooperation Council countries are modernizing interventional cardiology infrastructure, while Africa’s public health initiatives aim to expand access to percutaneous therapies despite budget constraints.

Asia-Pacific presents a heterogeneous landscape: mature East Asian markets exhibit strong R&D collaborations and high-volume manufacturing, while Southeast Asian nations are investing heavily in hospital upgrades. India’s emergent medical device policy and China’s localization mandates are catalyzing indigenous innovation. Across all regions, digital health integration and outcome‐based contracting are gaining prominence as payers seek quantifiable value.

Competitive Landscape and Strategic Positioning of Key Players

The competitive landscape is defined by a mix of multinational corporations and specialized innovators. Leading firms such as Abbott Laboratories and Boston Scientific Corporation continue to invest heavily in R&D to bolster their portfolios of drug‐eluting stents and bioresorbable scaffolds, while Medtronic plc leverages its global footprint to expand distribution of next‐generation atherectomy and intravascular imaging systems.

B. Braun Melsungen AG and Cardinal Health, Inc. focus on integrated cath lab consumables and logistics solutions, whereas Cook Medical, Inc. and Cordis Corporation strengthen their catheter and guidewire offerings through targeted acquisitions. Biotronik SE & Co. KG and Biosensors International Group, Ltd. differentiate with proprietary polymer technologies and sensor‐enabled devices.

Innovators like Infraredx, Inc. and Elixir Medical Corporation are pioneering optical coherence tomography and bioresorbable platforms, respectively, while OrbusNeich Medical Company Ltd. and STENTYS S.A. pursue the niche of self‐expanding stent architectures. Meril Life Sciences Pvt. Ltd. and MicroPort Scientific Corporation capitalize on cost‐competitive production in Asia, and Terumo Corporation alongside Terumo Medical Corporation extend their strength in hydrophilic guidewires and balloon catheter technologies. Collectively, these players drive continuous evolution in the market by orchestrating strategic partnerships, patent filing strategies and clinical publications.

Actionable Recommendations for Driving Sustainable Growth

Industry leaders should pursue a multi‐pronged strategy to secure market leadership. First, supply chain diversification and localization must mitigate tariff exposure and ensure resilience. Second, doubling down on bioabsorbable and nanotechnology platforms will address unmet clinical needs in complex lesions. Third, integrating AI‐driven analytics and remote monitoring capabilities into devices will enhance procedural precision and foster value‐based contracting.

Furthermore, tailored solutions that address demographic nuances-such as pediatric vessel sizing or gender‐specific restenosis patterns-will unlock new segments. Collaborative R&D partnerships with academic centers can expedite breakthrough innovations, while proactive engagement with regulators and payers will smooth reimbursement pathways. Lastly, expanding training programs and simulation‐based education for interventionalists will accelerate adoption and optimize real‐world outcomes.

Conclusion: Navigating Complexity to Unlock Future Potential

The coronary interventional devices ecosystem is at an inflection point where technological innovation, regulatory evolution and global trade dynamics converge. Stakeholders who navigate tariff headwinds, embrace advanced segmentation insights and adapt to region‐specific market drivers will emerge as leaders. The continuous refinement of bioabsorbable materials, AI integration and digital connectivity will further elevate procedural success and patient quality of life.

As the landscape becomes more complex, decision‐makers must prioritize agility, forging collaborations that span academia, industry and healthcare providers. By doing so, they will not only capture emerging opportunities but also contribute to the evolution of interventional cardiology, ultimately improving outcomes for patients worldwide.

Market Segmentation & Coverage

This research report categorizes the Coronary Interventional Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Atherectomy Devices
    • Laser Atherectomy
    • Orbital Atherectomy
    • Rotational Atherectomy
  • Catheters
    • Balloon Catheters
    • Diagnostic Catheters
    • Guiding Catheters
  • Embolic Protection Devices
    • Distal Occlusion Devices
    • Filter Devices
    • Proximal Occlusion Devices
  • Guidewires
    • Hydrophilic Guidewires
    • Non-Hydrophilic Guidewires
  • Stents
    • Bare Metal Stents
    • Bioabsorbable Stents
    • Bioresorbable Vascular Scaffold
    • Drug-Eluting Stents
    • Dual Therapy Stents
  • Academic And Research Institutes
    • Research Labs
    • University Hospitals
  • Ambulatory Surgical Centers
    • Multi-Specialty Centers
    • Single Specialty Centers
  • Hospitals
    • Private Hospitals
    • Public Hospitals
  • Metallic Stents
    • Cobalt-Chromium
    • Nickel-Titanium
    • Stainless Steel
  • Polymeric Stents
    • Biodegradable Polymers
    • Non-Biodegradable Polymers
  • Angioplasty
    • Atherectomy
    • Balloon Angioplasty
    • Laser Angioplasty
  • Valve Repair And Replacement
    • Transcatheter Aortic Valve Replacement (TAVR)
    • Transcatheter Mitral Valve Repair
  • Age Group
    • Adult
    • Geriatric
    • Pediatric
  • Gender
    • Female
    • Male
  • Coronary Artery Disease
    • Myocardial Infarction
    • Stable Angina
    • Unstable Angina
  • Peripheral Artery Disease
    • Critical Limb Ischemia
    • Intermittent Claudication
  • Structural Heart Disease
    • Aortic Stenosis
    • Mitral Regurgitation
  • Bioabsorbable Technologies
    • Fully Degradable Platforms
    • Partially Degradable Platforms
  • Nanotechnology Usage
  • Novel Scaffolding Techniques

This research report categorizes the Coronary Interventional Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Coronary Interventional Devices Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • Cordis Corporation
  • Elixir Medical Corporation
  • Infraredx, Inc.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Company Ltd.
  • STENTYS S.A.
  • Terumo Corporation
  • Terumo Medical Corporation

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Coronary Interventional Devices Market, by Device Type
8.1. Introduction
8.2. Atherectomy Devices
8.2.1. Laser Atherectomy
8.2.2. Orbital Atherectomy
8.2.3. Rotational Atherectomy
8.3. Catheters
8.3.1. Balloon Catheters
8.3.2. Diagnostic Catheters
8.3.3. Guiding Catheters
8.4. Embolic Protection Devices
8.4.1. Distal Occlusion Devices
8.4.2. Filter Devices
8.4.3. Proximal Occlusion Devices
8.5. Guidewires
8.5.1. Hydrophilic Guidewires
8.5.2. Non-Hydrophilic Guidewires
8.6. Stents
8.6.1. Bare Metal Stents
8.6.2. Bioabsorbable Stents
8.6.3. Bioresorbable Vascular Scaffold
8.6.4. Drug-Eluting Stents
8.6.5. Dual Therapy Stents
9. Coronary Interventional Devices Market, by End User
9.1. Introduction
9.2. Academic And Research Institutes
9.2.1. Research Labs
9.2.2. University Hospitals
9.3. Ambulatory Surgical Centers
9.3.1. Multi-Specialty Centers
9.3.2. Single Specialty Centers
9.4. Hospitals
9.4.1. Private Hospitals
9.4.2. Public Hospitals
10. Coronary Interventional Devices Market, by Material Type
10.1. Introduction
10.2. Metallic Stents
10.2.1. Cobalt-Chromium
10.2.2. Nickel-Titanium
10.2.3. Stainless Steel
10.3. Polymeric Stents
10.3.1. Biodegradable Polymers
10.3.2. Non-Biodegradable Polymers
11. Coronary Interventional Devices Market, by Procedure Type
11.1. Introduction
11.2. Angioplasty
11.2.1. Atherectomy
11.2.2. Balloon Angioplasty
11.2.3. Laser Angioplasty
11.3. Valve Repair And Replacement
11.3.1. Transcatheter Aortic Valve Replacement (TAVR)
11.3.2. Transcatheter Mitral Valve Repair
12. Coronary Interventional Devices Market, by Patient Demographics
12.1. Introduction
12.2. Age Group
12.2.1. Adult
12.2.2. Geriatric
12.2.3. Pediatric
12.3. Gender
12.3.1. Female
12.3.2. Male
13. Coronary Interventional Devices Market, by Application Type
13.1. Introduction
13.2. Coronary Artery Disease
13.2.1. Myocardial Infarction
13.2.2. Stable Angina
13.2.3. Unstable Angina
13.3. Peripheral Artery Disease
13.3.1. Critical Limb Ischemia
13.3.2. Intermittent Claudication
13.4. Structural Heart Disease
13.4.1. Aortic Stenosis
13.4.2. Mitral Regurgitation
14. Coronary Interventional Devices Market, by Technology Advancements
14.1. Introduction
14.2. Bioabsorbable Technologies
14.2.1. Fully Degradable Platforms
14.2.2. Partially Degradable Platforms
14.3. Nanotechnology Usage
14.4. Novel Scaffolding Techniques
15. Americas Coronary Interventional Devices Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Coronary Interventional Devices Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Coronary Interventional Devices Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. B. Braun Melsungen AG
18.3.3. Biosensors International Group, Ltd.
18.3.4. Biotronik SE & Co. KG
18.3.5. Boston Scientific Corporation
18.3.6. Cardinal Health, Inc.
18.3.7. Cook Medical, Inc.
18.3.8. Cordis Corporation
18.3.9. Elixir Medical Corporation
18.3.10. Infraredx, Inc.
18.3.11. Medtronic plc
18.3.12. Meril Life Sciences Pvt. Ltd.
18.3.13. MicroPort Scientific Corporation
18.3.14. OrbusNeich Medical Company Ltd.
18.3.15. STENTYS S.A.
18.3.16. Terumo Corporation
18.3.17. Terumo Medical Corporation
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix

List of Figures
FIGURE 1. CORONARY INTERVENTIONAL DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CORONARY INTERVENTIONAL DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CORONARY INTERVENTIONAL DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2024 VS 2030 (%)
FIGURE 20. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. CORONARY INTERVENTIONAL DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. CORONARY INTERVENTIONAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2024


List of Tables
TABLE 1. CORONARY INTERVENTIONAL DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DIAGNOSTIC CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDING CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DISTAL OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY FILTER DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROXIMAL OCCLUSION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HYDROPHILIC GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY NON-HYDROPHILIC GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLD, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DUAL THERAPY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY UNIVERSITY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MULTI-SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY SINGLE SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COBALT-CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY NICKEL-TITANIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY LASER ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR), BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TRANSCATHETER MITRAL VALVE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MYOCARDIAL INFARCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY INTERMITTENT CLAUDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STRUCTURAL HEART DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AORTIC STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MITRAL REGURGITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STRUCTURAL HEART DISEASE, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY FULLY DEGRADABLE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PARTIALLY DEGRADABLE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY NANOTECHNOLOGY USAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY NOVEL SCAFFOLDING TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STRUCTURAL HEART DISEASE, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STRUCTURAL HEART DISEASE, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 169. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 170. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STRUCTURAL HEART DISEASE, 2018-2030 (USD MILLION)
TABLE 171. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 172. BRAZIL CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 173. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 174. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 175. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 176. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 177. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 178. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 179. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 181. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 182. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 183. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 184. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 185. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 186. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 187. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 188. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 189. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 190. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 191. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 192. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 193. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 194. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 195. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STRUCTURAL HEART DISEASE, 2018-2030 (USD MILLION)
TABLE 196. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 197. CANADA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 198. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 199. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 200. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 201. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 202. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 203. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 204. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 206. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 207. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 208. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 209. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 211. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 212. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 213. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 214. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 215. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 216. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 217. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 218. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 219. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 220. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STRUCTURAL HEART DISEASE, 2018-2030 (USD MILLION)
TABLE 221. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 222. MEXICO CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 242. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 243. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 244. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 245. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STRUCTURAL HEART DISEASE, 2018-2030 (USD MILLION)
TABLE 246. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 247. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 248. UNITED STATES CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY APPLICATION TYPE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STRUCTURAL HEART DISEASE, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY TECHNOLOGY ADVANCEMENTS, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY BIOABSORBABLE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ATHERECTOMY DEVICES, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY CATHETERS, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY GUIDEWIRES, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY STENTS, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY VALVE REPAIR AND REPLACEMENT, 2018-2030 (USD MILLION)
TABLE 291. AUSTRALIA CORONARY INTERVENTIONAL DEVICES MARKET SIZE, BY

Companies Mentioned

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical, Inc.
  • Cordis Corporation
  • Elixir Medical Corporation
  • Infraredx, Inc.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Company Ltd.
  • STENTYS S.A.
  • Terumo Corporation
  • Terumo Medical Corporation

Methodology

Loading
LOADING...

Related Topics

Related Reports

Interventional Cardiology Devices Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals & Clinics, Ambulatory Surgical Centers & Others), By Product, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Interventional Cardiology Devices Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals & Clinics, Ambulatory Surgical Centers & Others), By Product, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • Global
From
Interventional Cardiology Devices Market by Device Type (Catheters, Closure Devices, Guidewires), Material (Metals, Polymers), Technology, Application, End Users - Global Forecast 2025-2030 - Product Image

Interventional Cardiology Devices Market by Device Type (Catheters, Closure Devices, Guidewires), Material (Metals, Polymers), Technology, Application, End Users - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Interventional Cardiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Interventional Cardiology Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
LAMEA Interventional Cardiology Devices Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals & Clinics, Ambulatory Surgical Centers & Others), By Product, By Country and Growth Forecast, 2023 - 2030 - Product Image

LAMEA Interventional Cardiology Devices Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals & Clinics, Ambulatory Surgical Centers & Others), By Product, By Country and Growth Forecast, 2023 - 2030

  • Report
  • Africa, Middle East
From
Interventional Cardiology Devices Market - Product Image

Interventional Cardiology Devices Market

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.